Sanofi

News and Events

A technologist, wearing purple glove and safety glasses performing structural analysis by HDX-MS, handling samples with precision.

First quarter 2026

Q1 2026 results will be reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation will be followed by a Q&A session.

Press Releases


March 31, 2026
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

March 28, 2026
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

March 27, 2026
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

Upcoming Events

23Apr

2026

First quarter 2026

Q1 2026 results will be reviewed by management during a live audio webcast with the financial community on April 23, 2026. The presentation will be followed by a Q&A session.

13:00 - 14:00 CET (7:00am - 8:00am EST)

Quarterly results

Discover more

30Jul

2026

Second Quarter 2026

Second quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation will be followed by a Q&A session.

Quarterly results


30Oct

2026

Third Quarter 2026

Third quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on October 30, 2026. The presentation will be followed by a Q&A session.

Quarterly results


Past Events

29Jan

2026

Fourth Quarter & Full Year 2025 Results

Fourth quarter and full year 2025 results were reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation was followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EDT)

Quarterly results

Discover more

24Oct

2025

Third Quarter 2025

Third quarter 2025 results were reviewed by management during a live audio webcast with the financial community on October 24, 2025. The presentation was followed by a Q&A session.

Quarterly results

Discover more

31Jul

2025

Second Quarter 2025

Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation was followed by a Q&A session.

Quarterly results

Discover more